𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Randomized Controlled Trial of Danoprevir Plus Peginterferon Alfa-2a and Ribavirin in Treatment-Naïve Patients With Hepatitis C Virus Genotype 1 Infection

✍ Scribed by Marcellin, Patrick; Cooper, Curtis; Balart, Luis; Larrey, Dominique; Box, Terry; Yoshida, Eric; Lawitz, Eric; Buggisch, Peter; Ferenci, Peter; Weltman, Martin; Labriola–Tompkins, Emily; Le Pogam, Sophie; Nájera, Isabel; Thomas, Denise; Hooper, Gregory; Shulman, Nancy S.; Zhang, Ying; Navarro, Mercidita T.; Lim, Chin Yin; Brunda, Michael; Terrault, Norah A.; Yetzer, Ellen S.

Book ID
121283463
Publisher
Elsevier Science
Year
2013
Tongue
English
Weight
517 KB
Volume
145
Category
Article
ISSN
0016-5085

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Treatment of insulin resistance with met
Treatment of insulin resistance with metformin in naïve genotype 1 chronic hepatitis C patients receiving peginterferon alfa-2a plus ribavirin
✍ Manuel Romero-Gómez; Moisés Diago; Raúl J. Andrade; José L. Calleja; Javier Salm 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 309 KB 👁 1 views

Insulin resistance affects sustained virological response (SVR) in chronic hepatitis C. To know whether adding metformin to standard antiviral treatment improves SVR, we conducted a prospective, multicentered, randomized, double-blinded, placebo-controlled trial in 19 Spanish hospitals, including 12